📖 Find out more insights like these by clicking on the full article: doi.org/10.1016/j.tr...
02.03.2026 11:01
👍 0
🔁 0
💬 0
📌 0
📖 Find out more insights like these by clicking on the full article: doi.org/10.1016/j.tr...
✏️ Brain metastasis has unique mechanisms that allow cancer cells to travel to the brain and survive there.
✏️ The disease remains a major challenge, affecting up to 30% of adult cancer patients.
✏️ Recent advances are offering new, more precise and integrated treatments.
📢The Volume II of “The Evolving Landscape of Brain Metastasis” in Trends in Cancer brings you insights on brain metastasis shaping research and treatment like these 👇
📅 This week, RENACER joined GEPAC at the VIII Spanish Cancer Summit, recognizing the vital role of the cancer advocacy movement. 💟Thank you for your essential work in supporting patients, advancing research, and strengthening collaboration in the fight against cancer.
📢 We want to thank @heraldo.es, @elperiodico.com, @infobae.bsky.social, @democrataes.bsky.social, and other media that have highlighted Volume II of Trends in Cancer, ‘The Evolving Landscape of Brain Metastasis’, by Manuel Valiente's group. Thank you for helping science reach beyond the lab!
Read the full news here: www.cnio.es/noticias/el-...
🤝 Hope is born when committed people come together to improve lives.
Today, on #WorldCancerDay, we prove that this hope is happening. As pointed out by the brain metastasis research group led by Manuel Valiente, we are moving closer to advances that can improve patients' lives.
🔗More information:
www.cnio.es/en/news/the-...
🧬The CNIO Biobank continues to grow as a key resource for research.
Nearly 56,000 samples from the CNIO Biobank are now part of the world’s largest network of biological resources, available to the entire scientific community.
📖New article in Trends in Cancer. Volume II of “The evolving landscape of brain metastasis” has been published—a review coordinated by Manuel Valiente, 8 years after Volume I, with contributions from 17 leading figures in the field.
🔗Read full article: doi.org/10.1016/j.tr...
📬 Our last newsletter is out
We closed 2025 with a special edition that highlights the year’s main milestones, the scientific advances driven by the network, and the objectives that will shape RENACER’s work in 2026.
🔗Read it here: mailchi.mp/d89158a1f2f5...
2025 was a year of growth and collaboration for #RENACER, with advances shared at key forums. 💡In 2026, we continue connecting research for patient benefit.
🔗 Read the highlights from our General Assembly:
Latests talks and seminars from the #RENACER team, sharing new advances in neuro-oncology:
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
Last October, we held the 5th General Assembly of RENACER, a key meeting that brought together several experts to share progress and strengthen collaboration in #BrainMetastasis.
📰 Read here IM Médico's summary and key insights:
#RENACER unites 5 multidisciplinary groups across Spain to advance research and improve care in #BrainMetastasis. You can meet them all on our website: renacerbrainmet.org/members-coor...
High pSTAT3 in reactive astrocytes is linked to higher intracranial recurrence and shorter PFS in triple-negative #BreastCancer #BrainMetastases. STAT3 emerges as a potential prognostic biomarker and therapeutic target.
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
Manuel Valiente shared with the researchers at the CNIO the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance
🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Everything is ready for the 5th RENACER General Assembly at the Ramón Areces Foundation! We look forward to welcoming clinicians, researchers, patient representatives, and collaborators to share the latest advances in brain metastases.
Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence.
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment.
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...
📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks.
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
🧠 Save the Date!
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw
“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.
The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊
🔗 canceratlas.cancer.org
Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay
🔗 Full interview:
🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...